"The Once A Day Protease Inhibitor Regimens"
type: MedicalStudy
description: "PIQD: The Once a Day Protease Inhibitor Regimens." Ritonavir Boosted Atazanavir vs. Ritonavir Boosted Fosamprenavir Used in Combination With Tenofovir and Emtricitabine in HIV-1 Infected Antiretroviral Treatment-Naïve Patients.
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE4
start date: 2004-05
end date: 2010-03
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00242216
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: The University of Texas Health Science Center, Houston
study subject: HIV Infections
keywords: PHASE4
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: HIV Infections

AI Analytics
type: Organization